EQS-News: Cleantech Innovator BioLargo's Hard Work Is Coming To Fruition


Werte in diesem Artikel
Aktien

0.08 USD 0.00 USD -1.18 %

EQS-News: Benzinga / Key word(s): Science
Cleantech Innovator BioLargo's Hard Work Is Coming To Fruition

23.07.2025 / 19:01 CET/CEST
The issuer is solely responsible for the content of this announcement.

Werbung


By Meg Flippin

DETROIT, MICHIGAN - July 23, 2025 (NEWMEDIAWIRE) - Dennis Calvert, president and CEO of Biolargo Inc. (OTC: BLGO), was recently a guest on Benzinga’s All-Access. 

6880d39fda846f627638464a_1
Werbung

BioLargo is a cleantech and life sciences company that invents, develops and commercializes innovative platform technologies to solve challenging environmental problems. The company creates subsidiaries and is currently focused on four areas: odor and VOC controls, PFAS groundwater remediation and treatment, battery storage technology and medical devices.

“All of these have had long development cycles, lots of R&D, big vision, huge competition and barriers to entry,” Calvert told Benzinga during the interview. “Now we’re at that point that it’s all starting to pay off, find the channel, make the deal, reap the harvest. We've been planting seeds for a long time.” 

Among the businesses BioLargo is focused on, Calvert said he is excited about the company’s battery storage unit Cellinity, which recently received third-party validation. Cellinity is used in grid-scale battery energy storage applications. Calvert said battery storage is a hot market right now as it supports AI expansion, given that the energy available today is inefficient to meet the growing demand. As for the company’s future growth, Calvert says Biolargo is one of those companies that takes patience, but that long view is now starting to pay off. 

Werbung

Watch the full interview here: 
https://www.youtube.com/watch?v=OlH4H2MrgLI

Featured image from Shutterstock.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.

This content was originally published on Benzinga. Read further disclosures here.


News Source: Benzinga


23.07.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Benzinga
United States
ISIN: US09065A1007
EQS News ID: 2173838

 
End of News EQS News Service

2173838  23.07.2025 CET/CEST

Werbung

Biolargo Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Biolargo nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.